Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01282099 · ClinicalTrials.gov registry record

A Critical Appraisal of the Role of Near Infrared Spectroscopy (NIRS) in the Pediatric Intensive Care Unit (PICU)

A clinical trial of Pediatric Intensive Care Unit, sponsored by Akron Children's Hospital.

Completed
Registry status
22
Enrollment target
1
Study location

NCT01282099 is a study of Pediatric Intensive Care Unit that has completed, run by Akron Children's Hospital. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01282099, a study of Pediatric Intensive Care Unit, has completed, sponsored by Akron Children's Hospital.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

While near infrared spectroscopy is an exciting technology, scientific rigor is required in order to optimize its appropriate use in the clinical arena. This study will explore the feasibility and clinical applicability of data obtained from the NIRS device. The ability to noninvasively monitor peripheral perfusion remains an area of intense research. The most widely used method is pulse oximetry. The international mandate of its use in operating rooms in the early 1990s after the publication of the Harvard minimum standards for monitoring speaks to its unquestionable utility. Its pervasive application notwithstanding, pulse oximetry merely provides a calibrated ratio of arterial and venous hemoglobin saturation. While this data is valuable, time-tested, and even may hold the promise of accurately noninvasively trending cardiac output, cellular dysmetabolism -- hallmarks of vulnerable, yet viable tissue beds -- are beyond the predictive values of currently available devices.

Study Locations (1)

Ohio

  • Akron Children's Hospital - Akron

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2011-09
Est. Completion 2013-02

Sponsor

Akron Children's Hospital

27 total trials

What the Registry Record Tells You About NCT01282099

The ClinicalTrials.gov registry entry for NCT01282099 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric Intensive Care Unit appearing as the primary indexed condition, and to 0 interventions.

NCT01282099 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01282099 about?

NCT01282099 is a clinical study titled "A Critical Appraisal of the Role of Near Infrared Spectroscopy (NIRS) in the Pediatric Intensive Care Unit (PICU)". While near infrared spectroscopy is an exciting technology, scientific rigor is required in order to optimize its appropriate use in the clinical arena. This study will explore the feasibility and clinical applicability of data obtained from the NIRS device. The ability to noninvasively monitor peri...

What is the current status of trial NCT01282099?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-09. Estimated completion is 2013-02.

What conditions does trial NCT01282099 study?

This clinical trial studies the following conditions: Pediatric Intensive Care Unit.

Who is sponsoring clinical trial NCT01282099?

This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01282099 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.